Cargando…
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection
Heparan sulfate proteoglycan associated with endothelial cells in normal blood vessels inhibits intravascular coagulation and egress of blood cells and plasma proteins, key features of hyperacute rejection. It was shown herein that exposure of cultured porcine endothelium to human serum as a source...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187844/ https://www.ncbi.nlm.nih.gov/pubmed/2139104 |
Ejemplares similares
-
Heparan sulfate is a plasma biomarker of acute cellular allograft rejection
por: Barbas, Andrew S., et al.
Publicado: (2018) -
Heparan sulfates and heparan sulfate binding proteins in sepsis
por: Liao, Yi-En, et al.
Publicado: (2023) -
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
por: Nagarajan, Arvindhan, et al.
Publicado: (2018) -
Hyperacute Rejection of a Living Unrelated Kidney Graft
por: Tittelbach-Helmrich, Dietlind, et al.
Publicado: (2014) -
Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function
por: Pretorius, Danielle, et al.
Publicado: (2022)